-
Electronic (PDF)
-
Site License
-
Enterprisewide
IMMD Inc. - Product Pipeline Review - Q4 2010
Global Markets Direct, November 2010, Pages: 26
IMMD Inc. – Product Pipeline Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “IMMD Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- IMMD Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of IMMD Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of IMMD Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the IMMD Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate IMMD Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of IMMD Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the IMMD Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with IMMD Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of IMMD Inc. and identify potential opportunities in those areas.
List of Tables
List of Figures
IMMD Inc. Snapshot
IMMD Inc. Overview
Key Information
Key Facts
IMMD Inc. – Research and Development Overview
Key Therapeutic Areas
IMMD Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
IMMD Inc. – Pipeline Products Glance
IMMD Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
IMMD Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
IMMD Inc. – Drug Profiles
IMD-1041
Product Description
Mechanism of Action
R&D Progress
IMD-0354
Product Description
Mechanism of Action
R&D Progress
IMD-0560
Product Description
Mechanism of Action
R&D Progress
IMD-2560
Product Description
Mechanism of Action
R&D Progress
IMD-4482
Product Description
Mechanism of Action
R&D Progress
IMD-4852
Product Description
Mechanism of Action
R&D Progress
IMMD Inc. – Pipeline Analysis
IMMD Inc. – Pipeline Products by Therapeutic Class
IMMD Inc. Pipeline Products By Target
IMMD Inc. – Pipeline Products by Route of Administration
IMMD Inc. – Pipeline Products by Molecule Type
IMMD Inc. – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
